Catherine C. Turkel - Net Worth and Insider Trading
Catherine C. Turkel Net Worth
The estimated net worth of Catherine C. Turkel is at least $15,751 dollars as of 2024-05-03. Catherine C. Turkel is the President of Eledon Pharmaceuticals Inc and owns about 4,926 shares of Eledon Pharmaceuticals Inc (ELDN) stock worth over $11,281. Catherine C. Turkel is also the Director of Lexaria Bioscience Corp and owns about 1,500 shares of Lexaria Bioscience Corp (LEXX) stock worth over $4,470. Details can be seen in Catherine C. Turkel's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Catherine C. Turkel has not made any transactions after 2023-02-09 and currently still holds the listed stock(s).
Transaction Summary of Catherine C. Turkel
Catherine C. Turkel Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Catherine C. Turkel owns 2 companies in total, including Eledon Pharmaceuticals Inc (ELDN) , and Lexaria Bioscience Corp (LEXX) .
Click here to see the complete history of Catherine C. Turkel’s form 4 insider trades.
Insider Ownership Summary of Catherine C. Turkel
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2019-05-21 | Chief Development Officer |
| LEXX | Lexaria Bioscience Corp | 2023-02-09 | director |
Catherine C. Turkel Latest Holdings Summary
Catherine C. Turkel currently owns a total of 2 stocks. Among these stocks, Catherine C. Turkel owns 4,926 shares of Eledon Pharmaceuticals Inc (ELDN) as of May 21, 2019, with a value of $11,281 and a weighting of 71.62%. Catherine C. Turkel also owns 1,500 shares of Lexaria Bioscience Corp (LEXX) as of February 9, 2023, with a value of $4,470 and a weighting of 28.38%.
Latest Holdings of Catherine C. Turkel
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ELDN | Eledon Pharmaceuticals Inc | 2019-05-21 | 4,926 | 2.29 | 11,281 |
| LEXX | Lexaria Bioscience Corp | 2023-02-09 | 1,500 | 2.98 | 4,470 |
Holding Weightings of Catherine C. Turkel
Catherine C. Turkel Form 4 Trading Tracker
According to the SEC Form 4 filings, Catherine C. Turkel has made a total of 1 transactions in Eledon Pharmaceuticals Inc (ELDN) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Eledon Pharmaceuticals Inc is the sale of 530 shares on May 21, 2019, which brought Catherine C. Turkel around $18,597.
According to the SEC Form 4 filings, Catherine C. Turkel has made a total of 1 transactions in Lexaria Bioscience Corp (LEXX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Lexaria Bioscience Corp is the acquisition of 1,500 shares on February 9, 2023, which cost Catherine C. Turkel around $4,260.
Insider Trading History of Catherine C. Turkel
- 1
Catherine C. Turkel Trading Performance
GuruFocus tracks the stock performance after each of Catherine C. Turkel's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Catherine C. Turkel is -43.19%. GuruFocus also compares Catherine C. Turkel's trading performance to market benchmark return within the same time period. The performance of stocks bought by Catherine C. Turkel within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Catherine C. Turkel's insider trading performs compared to the benchmark.
Performance of Catherine C. Turkel
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.03 | | | | | |
| Relative Return to S&P 500(%) | 1.72 | | | | | |
Catherine C. Turkel Ownership Network
Catherine C. Turkel Owned Company Details
What does Eledon Pharmaceuticals Inc do?
Who are the key executives at Eledon Pharmaceuticals Inc?
Catherine C. Turkel is the Chief Development Officer of Eledon Pharmaceuticals Inc. Other key executives at Eledon Pharmaceuticals Inc include other: See Explanation of Responses Biotechnology Value Fund L P , director & See Remarks Steven Perrin , and director & Chief Executive Officer David-alexandre C Gros .
Eledon Pharmaceuticals Inc (ELDN) Insider Trades Summary
Over the past 18 months, Catherine C. Turkel made no insider transaction in Eledon Pharmaceuticals Inc (ELDN). Other recent insider transactions involving Eledon Pharmaceuticals Inc (ELDN) include a net purchase of 1,978,932 shares made by Biotechnology Value Fund L P , and a net purchase of 1,000 shares made by Steven Perrin .
In summary, during the past 3 months, insiders sold 0 shares of Eledon Pharmaceuticals Inc (ELDN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Eledon Pharmaceuticals Inc (ELDN) were sold and 1,979,932 shares were bought by its insiders, resulting in a net purchase of 1,979,932 shares.
Eledon Pharmaceuticals Inc (ELDN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eledon Pharmaceuticals Inc Insider Transactions
Catherine C. Turkel Mailing Address
Above is the net worth, insider trading, and ownership report for Catherine C. Turkel. You might contact Catherine C. Turkel via mailing address: 19900 Macarthur Blvd., Suite 550, Irvine Ca 92612.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
